Showing results (21-30 of 36) with videos related to
Sort By:
Pageof 4
Brain Research|May 3, 1991
Dopamine receptor changes in untreated and (+)-PHNO-treated MPTP parkinsonian primatesG M Alexander, D L Brainard, S W Gordon, et al.The Journal of Antimicrobial Chemotherapy|May 1, 1995
Clearance of gentamicin during cardiac surgeryR M Heylen, A P Wilson, M Hichens, et al.Journal of Pharmaceutical and Biomedical Analysis|June 1, 1993
Determination of MK-852, a new fibrinogen receptor antagonist, in plasma and urine by radioimmunoassayA S Yuan, E L Hand, M Hichens, et al.Clinical Pharmacology and Therapeutics|July 1, 1982
Effects of enalapril, a new converting enzyme inhibitor, in hypertensionR K Ferguson, P H Vlasses, B N Swanson, et al.British Journal of Clinical Pharmacology|April 1, 1987
The pharmacokinetics of enalapril in hospitalized patients with congestive heart failureK Dickstein, A E Till, T Aarsland, et al.Drug Metabolism and Disposition: the Biological Fate of Chemicals|May 1, 1993
In vivo and in vitro metabolism studies on a class III antiarrhythmic agentS Vickers, C A Duncan, P H Kari, et al.Federation Proceedings|April 1, 1984
Initial evaluation of the non-sulfhydryl-containing converting enzyme inhibitor MK-521 in hypertensive humansH H Rotmensch, M Vincent, P H Vlasses, et al.Biopharmaceutics & Drug Disposition|July 1, 1984
Pharmacokinetics of repeated single oral doses of enalapril maleate (MK-421) in normal volunteersA E Till, H J Gomez, M Hichens, et al.Clinical Pharmacology and Therapeutics|December 1, 1985
The effect of renal function on enalapril kineticsD T Lowenthal, J D Irvin, D Merrill, et al.British Journal of Clinical Pharmacology|June 1, 1983
The effect of enalapril on serum prolactinW R McNabb, B A Brooks, F Noormohamed, et al.Pageof 4